Statistics for Top 10 Results
Filter:
Domain Registration Date Filter
1
Alnylam Submits Regulatory Application to the European Medicines ...
https://investors.alnylam.com/press-release?id=28461
2
Alnylam Pharmaceuticals Press Release | Jun 09, 2025
https://investors.alnylam.com/press-release?id=29101
3
Amvuttra | European Medicines Agency (EMA)
https://www.ema.europa.eu/en/medicines/human/EPAR/amvuttra
4
AMVUTTRA® (vutrisiran) Significantly Reduces Mortality and a ...
https://investors.alnylam.com/press-release?id=29051
5
Onpattro | European Medicines Agency (EMA)
https://www.ema.europa.eu/en/medicines/human/EPAR/onpattro
6
Alnylam to Share Progress Across its Transthyretin Amyloidosis ...
https://investors.alnylam.com/press-release?id=28986
7
Alnylam Receives Positive CHMP Opinion for Vutrisiran for the ...
https://investors.alnylam.com/press-release?id=28946
8
Alnylam Submits Regulatory Application to the European Medicines ...
https://finance.yahoo.com/news/alnylam-submits-regulatory-application-european-120000909.html
9
Alnylam Submits Vutrisiran Application to EMA for ATTR ...
https://synapse.patsnap.com/blog/alnylam-submits-vutrisiran-application-to-ema-for-attr-amyloidosis-with-cardiomyopathy
10
EMA-COMP Backs Alnylam's Orphan Drug Status Application For ...
https://www.clinicalleader.com/doc/ema-comp-backs-alnylam-s-orphan-drug-status-application-for-rnai-drug-0001